Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_assertion type Assertion NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_head.
- NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_assertion description "[However, whether and to which extent genetically determined differences in individual GR sensitivity influence 17-OHP screening levels in conditions of a pathological hypothalamus-pituitary-adrenal gland-axis stimulation and thus may explain false-negative screening results in those affected by CAH remains to be investigated.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_provenance.
- NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_assertion evidence source_evidence_literature NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_provenance.
- NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_assertion SIO_000772 19174530 NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_provenance.
- NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_assertion wasDerivedFrom befree-20150227 NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_provenance.
- NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_assertion wasGeneratedBy ECO_0000203 NP435234.RAFLEse2gmVfZ3eOMA1QBn1Obz4Cqd3waglLUAa9AjACQ130_provenance.